Kemri’s HPV cancer jab a game changer

HPV vaccine

A pupil at Ossen Primary School in Baringo North receives the HPV vaccine in 2019. A trial conducted in Kenya has shown that a new single dose vaccine is highly effective against the virus that causes cervical cancer.

Photo credit: File | Nation Media Group

On November 17, the world marked the inaugural year of a historic movement. It celebrated the first year the world committed to eliminate cancer.  Then the Kenya Medical Research Institute (Kemri) released an encouraging report on the KENya Single-dose HPV-vaccine Efficacy (KEN SHE) Study, pertaining to the trials on the single-dose HPV (human papillomavirus) vaccine.


You're all set to enjoy unlimited Prime content.